Related Experiment Videos
Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy
Abstract:
Twenty-one patients with metastatic germ cell tumors achieved only partial clinical tumor regression following chemotherapy, and underwent surgical biopsy or resection of the residual tumor deposits. Sixteen (76%) are at present clinically disease-free after a median 30 + months (range 17-50 months) from the time of surgery, and five (24%) died after 9-29 months. Adverse prognostic signs were the finding of persistent cancer at histopathological examination of the resected tumor masses, and the presence of elevated serum tumor markers at the time of surgery. Postchemotherapy surgery in this setting provides tissue for the prognostically important histopathological examination on which a decision regarding further chemotherapy may be based. In addition, it provides tumor bulk reduction in the cases of differentiated teratoma and persistent cancer.
Insights
Surgery after chemotherapy for metastatic germ cell tumors significantly improves outcomes. Post-chemotherapy surgery aids in prognostication and tumor reduction, leading to long-term disease-free survival for many patients.
Area of Science:
- Oncology
- Surgical Oncology
- Genitourinary Oncology
Background:
- Metastatic germ cell tumors (GCTs) often require multimodal treatment.
- Chemotherapy can induce tumor regression, but residual disease necessitates further management.
- Surgical intervention is crucial for assessing treatment response and achieving complete remission.
Purpose of the Study:
- To evaluate the efficacy and prognostic significance of post-chemotherapy surgery in patients with metastatic GCTs.
- To determine the impact of histopathological findings and tumor markers on patient outcomes.
- To assess the role of surgery in tumor bulk reduction.
Main Methods:
- Retrospective analysis of 21 patients with metastatic GCTs.
- Patients underwent surgical biopsy or resection of residual tumor deposits after chemotherapy.
- Histopathological examination of resected specimens and serum tumor marker levels were analyzed.
Main Results:
- 16 out of 21 patients (76%) achieved clinical disease-free status post-surgery.
- Median follow-up was 30+ months.
- Adverse prognostic factors included persistent cancer on histology and elevated tumor markers at surgery.
Conclusions:
- Post-chemotherapy surgery is a vital component in managing metastatic GCTs.
- Histopathological examination of resected tissue is critical for guiding further treatment decisions.
- Surgical resection improves survival rates and facilitates accurate prognostication.